|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/755 | (2006.01) |
| A61K 48/00 | (2006.01) | ||
| C12N 15/86 | (2006.01) |
| (11) | Number of the document | 3044231 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14771729.2 |
| Date of filing the European patent application | 2014-09-10 | |
| (97) | Date of publication of the European application | 2016-07-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation | 2020-11-10 |
| (86) | Number | PCT/US2014/054960 |
| Date | 2014-09-10 |
| (87) | Number | WO 2015/038625 |
| Date | 2015-03-19 |
| (30) | Number | Date | Country code |
| 201361877042 P | 2013-09-12 | US |
| (72) |
COLOSI, Peter Cameron, US
NATHWANI, Amit, GB
MCINTOSH, Jenny, GB
TUDDENHAM, Edward, GB
DAVIDOFF, Andrew, US
|
| (73) |
BioMarin Pharmaceutical Inc. ,
105 Digital Drive, Novato, CA 94949,
US
University College London , Gower Street, London WC1E 6BT, GB St. Jude Children's Research Hospital , 262 Danny Thomas Place, Memphis, TN 38105-3678, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | AAV vektoriai, apimantys VIII faktorių koduojantį geną |
| AAV VECTORS COMPRISING A GENE ENCODING FACTOR VIII |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 12 | 289.00 EUR |
| 2026-09-10 |